D'Alessandro Danilo 4

What Happened
Danilo D'Alessandro, Chief Financial Officer of ClearPoint Neuro (CLPT), acquired 1,085 shares of the company's common stock on June 30, 2026. The shares were purchased at $11.93 per share, for a total cost of approximately $12,944. The acquisition was reported on a Form 4 filed July 2, 2026.

Key Details

• Transaction date: 2026-06-30; Filing date: 2026-07-02 (Form 4 accession 0001193125-26-294476).
• Transaction type: Acquisition under Employee Stock Purchase Plan (ESPP) — coded as "A" (award/acquisition).
• Price and value: 1,085 shares at $11.93 each; total ≈ $12,944.
• Footnote: Shares were purchased under the ESPP purchase period Jan 1, 2026–Jun 30, 2026 and were bought at the lesser of 85% of the fair market value on the first or last day of the period (i.e., a 15% discount).
• Shares owned after the transaction: not specified in the provided filing details.
• Timeliness: Form 4 was filed July 2, 2026; the filing itself does not indicate a tardy report.

Context
This was an ESPP purchase — a routine employee benefit that allows discounted purchases of company stock (here, 15% off the applicable fair market value). Purchases via ESPPs are acquisitions rather than sales and are often viewed as a small additional ownership stake by an insider; they do not, by themselves, indicate broader strategic moves.